Teniposide (trade name Vumon) is a chemotherapeutic medication used in the
treatment of childhood acute lymphocytic leukemia (ALL), Hodgkin's lymphoma, ...
Drug type: Teniposide is an anti-cancer ("antineoplastic" or "cytotoxic")
chemotherapy drug. This medication is classified as an "topoisomerase II
Teniposide inhibits DNA synthesis by forming a complex with topoisomerase II
and DNA. This complex induces breaks in double stranded DNA and prevents ...
Teniposidum is a semisynthetic derivative of PODOPHYLLOTOXIN that exhibits
antitumor activity. Teniposide inhibits DNA synthesis by forming a complex with ...
VUMON (teniposide injection) is a cytotoxic drug which should be administered
under the supervision of a qualified physician experienced in the use of cancer ...
Jan 22, 2014 ... The chemotherapy drug teniposide treats acute lymphoblastic leukaemia in
adults or children. The possible side effects include a low ...
Easy to read patient leaflet for teniposide. Includes indications, proper use,
special instructions, precautions, and possible side effects.
Jan 13, 2016 ... Teniposide (Vumon®, VM-26) is an intravenous chemotherapy used in the
treatment of Acute Lymphocytic Leukemia, non-Hodgkin's ...
Medscape - Indication-specific dosing for vm 26, Vumon (teniposide), frequency-
based adverse effects, comprehensive interactions, contraindications, ...
Structure, properties, spectra, suppliers and links for: Teniposide, 29767-20-2.